BRIEF-EMA Says Looking At Extension Of Novavax COVID Shot For Adolescents

European Medicines Agency (EMA):

* STARTED EVALUATING AN APPLICATION TO EXTEND THE USE OF NOVAVAX'S COVID-19 VACCINE, NUVAXOVID, TO ADOLESCENTS AGED 12 TO 17 Further company coverage:

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)